Scientists discover new way to tackle inflammatory diseases

by Shemina Davis
Scientists discover new way to tackle inflammatory diseases
Zebrafish inflammatory neutrophils (in red) leave sites of inflammation when treated with Tanshinone

Researchers at the University of Sheffield have found a potential new way to treat common and largely incurable inflammatory conditions like chronic obstructive pulmonary disease (COPD).

Normally when a person is injured or gets an infection, the body sends specialist white blood cells (neutrophils) to clean up the area, resulting in it becoming red and inflamed. The inflammation usually ebbs away over time but in certain diseases the inflammation remains, doing more damage to surrounding tissue.

Now scientists from the University of Sheffield may have found a solution using an ingredient found in traditional Chinese medicine which has inflammation reducing capabilities, giving it the potential to treat a range of diseases.

By screening drugs in zebrafish, researchers found a compound, Tanshinone IIA, which reduced inflammation, removing neutrophils by causing them to die at the wound and by moving them away from the wound - a completely new way to treat . The discovery has, for the first time, given scientists the opportunity to develop anti-inflammatory drugs which would not increase the risk of infection like current treatments.

Professor Stephen Renshaw, from the University's Department of Infection and Immunity, said: "Chronic inflammatory diseases are a major cause of illness and death worldwide and many of these, such as chronic (COPD) are characterised by the persistence of inflammatory neutrophils. We believe targeting the neutrophil would be a new way to bring about healing in these conditions.

"Sending immune cells away from damaged tissue might be a good way to allow the damage to heal while still allowing those to protect us against infection."

Professor Renshaw said it was not known at the moment precisely how Tanshinone IIA helps to migrate away from the wound but said research would continue.

He added: "Tanshinone IIA might be the first in a new class of drugs that allows us to tackle some devastating conditions, benefiting thousands of sufferers."

The research work was funded by the Medical Research Council (MRC) and the full paper will be published in the Science Translational Medicine journal.

add to favorites email to friend print save as pdf

Related Stories

Nanoparticles target anti-inflammatory drugs where needed

Feb 23, 2014

Researchers at the University of Illinois at Chicago have developed a system for precisely delivering anti-inflammatory drugs to immune cells gone out of control, while sparing their well-behaved counterparts. ...

New blood cells fight brain inflammation

Feb 16, 2014

Hyperactivity of our immune system can cause a state of chronic inflammation. If chronic, the inflammation will affect our body and result in disease. In the devastating disease multiple sclerosis, hyperactivity of immune ...

Recommended for you

Gamers helping in Ebola research

11 hours ago

Months before the recent Ebola outbreak erupted in Western Africa, killing more than a thousand people, scientists at the University of Washington's Institute for Protein Design were looking for a way to stop the deadly virus.

Carcinogenic role of a protein in liver decoded

14 hours ago

The human protein EGFR controls cell growth. It has mutated in case of many cancer cells or exists in excessive numbers. For this reason it serves as a point of attack for target-oriented therapies. A study ...

A new way to diagnose malaria, using magnetic fields

Aug 31, 2014

Over the past several decades, malaria diagnosis has changed very little. After taking a blood sample from a patient, a technician smears the blood across a glass slide, stains it with a special dye, and ...

User comments